SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?


To: Perry who wrote (2549)5/18/1998 9:47:00 AM
From: StormRider  Respond to of 9523
 
I don't know, but I just saw this headline:

LAWSUIT IN NEW YORK SEEKS INSURANCE COVERAGE FOR PFIZER'S VIAGRA



To: Perry who wrote (2549)5/18/1998 11:07:00 AM
From: BigKNY3  Read Replies (1) | Respond to of 9523
 
RESEARCH ALERT - Pfizer <PFE.N> raised at Gruntal

NEW YORK, May 18 (Reuters) - Gruntal & Co. said Monday it raised its rating on shares of Pfizer Inc. <PFE.N> to strong buy from buy.

Price target raised to $136 from $134/shr.

Shares stood at 105-13/16, up 1-3/16.

No further information was immediately available.

10:40 05-18-98